ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2023

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.

ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
Monaco Asset Management SAM 59,234$88,8510.03%
Marquette Asset Management, LLC 60,120$90,1800.02%
Lipe & Dalton 15,000$220.01%
XTX Topco Ltd 36,657$54,9860.01%
CANTOR FITZGERALD, L. P. 160,060$240,0900.01%
Renaissance Technologies 1,329,741$1,9950.00%
TWO SIGMA INVESTMENTS, LP 518,035$777,0530.00%
NWAM LLC 10,000$15,0000.00%
Ausdal Financial Partners, Inc. 10,000$15,0000.00%
TWO SIGMA ADVISERS, LP 492,700$739,0500.00%
External links

This page lists ADVERUM BIOTECHNOLOGIES INC's shareholders in Q3 2023. To view ADVERUM BIOTECHNOLOGIES INC's shareholder history, click here.